K. Relle

发表

Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models

J. Stasch, B. Hocher, L. Hoffmann, 2010, Journal of hypertension.

NO‐independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy

J. Stasch, B. Hocher, Christiane Rothkegel, 2006, British journal of pharmacology.

Soluble CD154 is a unique predictor of nonfatal and fatal atherothrombotic events in patients who have end-stage renal disease and are on hemodialysis.

G. Asmus, J. Stasch, B. Hocher, 2007, Journal of the American Society of Nephrology : JASN.

Endothelin-Converting Enzyme/Neutral Endopeptidase Inhibitor SLV338 Prevents Hypertensive Cardiac Remodeling in a Blood Pressure–Independent Manner

K. von Websky, B. Hocher, P. Guillaume, 2011, Hypertension.

Endothelin-1 overexpression and endothelial nitric oxide synthase knock-out induce different pathological responses in the heart of male and female mice.

B. Hocher, F. Theuring, K. Relle, 2013, Life sciences.

Cell‐type specific interaction of endothelin and the nitric oxide system: pattern of prepro‐ET‐1 expression in kidneys of l‐NAME treated prepro‐ET‐1 promoter‐lacZ‐transgenic mice

T. Slowinski, H. Neumayer, C. Bauer, 2007, The Journal of physiology.

Does endothelin B receptor deficiency ameliorate the induction of peritoneal fibrosis in experimental peritoneal dialysis?

S. Morgera, H. Neumayer, K. von Websky, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Lack of iNOS Impairs Endothelial Function in Endothelin-1 Transgenic Mice

B. Hocher, J. Galle, F. Theuring, 2008, Kidney and Blood Pressure Research.

Tissue specific activation of the endothelin system in severe acute liver failure.

W. Zidek, K. von Websky, B. Hocher, 2008, European journal of medical research.

Additional lack of iNOS attenuates diastolic dysfunction in aged ET-1 transgenic mice.

J. Stasch, C. Tschöpe, D. Westermann, 2008, Canadian journal of physiology and pharmacology.

Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice.

C. Wanner, S. Bachmann, C. Bauer, 2007, Journal of the American Society of Nephrology : JASN.

Impact of maternal body mass index on neonatal outcome

B. Hocher, R. Wauer, M. Godes, 2009, European journal of medical research.

The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure

B. Hocher, M. Godes, B Hocher, 2007, British journal of pharmacology.

Endothelin-1 overexpression restores diastolic function in eNOS knockout mice

J. Stasch, B. Hocher, F. Theuring, 2011, Journal of hypertension.

Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage.

K. von Websky, B. Hocher, Y. Sharkovska, 2011, Clinical laboratory.

Pulmonary fibrosis in L-NAME-treated mice is dependent on an activated endothelin system.

K. von Websky, B. Hocher, M. Godes, 2008, Canadian journal of physiology and pharmacology.

Endothelin-Converting Enzyme/Neutral Endopeptidase Inhibitor SLV338 Prevents Hypertensive Cardiac Remodeling in a Blood Pressure–Independent Manner

K. von Websky, B. Hocher, P. Guillaume, 2011, Hypertension.